Cite

    Holly Mason et al.. “Uptake and outcomes of adjuvant durvalumab following concurrent chemoradiotherapy in unresected stage 3 non-small-cell lung cancer.” Lung cancer, vol. 156, n.d., pp. S41–. http://access.bl.uk/ark:/81055/vdc_100131049552.0x000047